BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19843631)

  • 1. UNC45A confers resistance to histone deacetylase inhibitors and retinoic acid.
    Epping MT; Meijer LA; Bos JL; Bernards R
    Mol Cancer Res; 2009 Nov; 7(11):1861-70. PubMed ID: 19843631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells.
    Ohnuma-Ishikawa K; Morio T; Yamada T; Sugawara Y; Ono M; Nagasawa M; Yasuda A; Morimoto C; Ohnuma K; Dang NH; Hosoi H; Verdin E; Mizutani S
    Cancer Res; 2007 Feb; 67(3):1019-29. PubMed ID: 17283134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation.
    Yang QJ; Zhou LY; Mu YQ; Zhou QX; Luo JY; Cheng L; Deng ZL; He TC; Haydon RC; He BC
    Int J Oncol; 2012 Jul; 41(1):153-60. PubMed ID: 22485251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
    He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
    Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
    Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors regulate retinoic acid receptor beta expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms.
    De los Santos M; Zambrano A; Sánchez-Pacheco A; Aranda A
    Mol Endocrinol; 2007 Oct; 21(10):2416-26. PubMed ID: 17622583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors.
    Epping MT; Wang L; Plumb JA; Lieb M; Gronemeyer H; Brown R; Bernards R
    Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17777-82. PubMed ID: 17968018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.
    He LZ; Tolentino T; Grayson P; Zhong S; Warrell RP; Rifkind RA; Marks PA; Richon VM; Pandolfi PP
    J Clin Invest; 2001 Nov; 108(9):1321-30. PubMed ID: 11696577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors repress chondrosarcoma cell proliferation.
    Zhu J; Gu J; Ma J; Xu Z; Tao H
    J BUON; 2015; 20(1):269-74. PubMed ID: 25778327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERAP140/Nbla10993 is a novel favorable prognostic indicator for neuroblastoma induced in response to retinoic acid.
    Arai H; Ozaki T; Niizuma H; Nakamura Y; Ohira M; Takano K; Matsumoto M; Nakagawara A
    Oncol Rep; 2008 Jun; 19(6):1381-8. PubMed ID: 18497940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation.
    Rettig I; Koeneke E; Trippel F; Mueller WC; Burhenne J; Kopp-Schneider A; Fabian J; Schober A; Fernekorn U; von Deimling A; Deubzer HE; Milde T; Witt O; Oehme I
    Cell Death Dis; 2015 Feb; 6(2):e1657. PubMed ID: 25695609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the histone deacetylase complex in acute promyelocytic leukaemia.
    Lin RJ; Nagy L; Inoue S; Shao W; Miller WH; Evans RM
    Nature; 1998 Feb; 391(6669):811-4. PubMed ID: 9486654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
    Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
    Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of silenced α-N-catenin induces retinoic acid sensitivity in neuroblastoma cells.
    Clark RA; Newton M; Qiao J; Lee S; Chung DH
    Surgery; 2021 Nov; 170(5):1546-1553. PubMed ID: 34092372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid and evernyl-based menadione-triazole hybrid cooperate to induce differentiation of neuroblastoma cells.
    Mendonza JJ; Reddy ST; Dutta H; Makani VKK; Uppuluri VM; Jain N; Bhadra MP
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2651-2665. PubMed ID: 37097334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.
    Coffey DC; Kutko MC; Glick RD; Butler LM; Heller G; Rifkind RA; Marks PA; Richon VM; La Quaglia MP
    Cancer Res; 2001 May; 61(9):3591-4. PubMed ID: 11325825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
    Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
    Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.
    Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q
    J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid induces neuroblastoma cell death by inhibiting proteasomal degradation of retinoic acid receptor alpha.
    Nagai J; Yazawa T; Okudela K; Kigasawa H; Kitamura H; Osaka H
    Cancer Res; 2004 Nov; 64(21):7910-7. PubMed ID: 15520197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.